Key result
A genome-wide association scan in an Amish founder population identified novel associations for three rare-population Amish-enriched loci, including a GLTPD2 variant associated with lower SM(d40:0) levels (-0.76 SD, p=1.14E-12).
Why the study?
Previous studies were largely population-based and powered only for common variants, whereas founder populations can accelerate discovery of biology linked to rare population alleles affecting complex lipidomic pathways in CVD risk.
Observational (n=650)
No
A genome-wide association scan in an Amish founder population identified novel rare-population genetic variants associated with specific lipid species, providing new insights into lipidomic pathways.
Answers are grounded in this paper and cite their sources.
Should not yet change lipid assessment; hypothesis-generating for rare-variant effects on sphingolipids in founder populations.
Identifying the genetic determinants of inter-individual variation in lipid species (lipidome) may provide deeper understanding and additional insight into the mechanistic effect of complex lipidomic pathways in CVD risk and progression beyond simple traditional lipids. Previous studies have been largely population based and thus only powered to discover associations with common genetic variants. Founder populations represent a powerful resource to accelerate discovery of previously unknown biology associated with rare population alleles that have risen to higher frequency due to genetic drift. We performed a genome-wide association scan of 355 lipid species in 650 individuals from the Amish founder population including 127 lipid species not previously tested. To the best of our knowledge, we report for the first time the lipid species associated with two rare-population but Amish-enriched lipid variants: APOB_rs5742904 and APOC3_rs76353203. We also identified novel associations for 3 rare-population Amish-enriched loci with several sphingolipids and with proposed potential functional/causal variant in each locus including GLTPD2_rs536055318, CERS5_rs771033566, and AKNA_rs531892793. We replicated 7 previously known common loci including novel associations with two sterols: androstenediol with UGT locus and estriol with SLC22A8/A24 locus. Our results show the double power of founder populations and detailed lipidome to discover novel trait-associated variants.
No takes yet. Share an insight, caveat, or question.
Montasser et al. (2022) conducted an observational in Inter-individual variation in lipid species (lipidome) (n=650). Rare-population Amish-enriched genetic variants (e.g., GLTPD2_rs536055318) vs. Reference alleles was evaluated on Association of GLTPD2_rs536055318 with SM(d40:0) levels (-0.76 SD, p=1.14E-12). A genome-wide association scan in an Amish founder population identified novel associations for three rare-population Amish-enriched loci, including a GLTPD2 variant associated with lower SM(d40:0) levels (-0.76 SD, p=1.14E-12).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: